Associated Papers
Mutant PIK3CA is a targetable driver alteration in histiocytic neoplasms.
Durham BH et al.
Blood Advances, 2023
Characterization of PIK3CA and PIK3R1 somatic mutations in Chinese breast cancer patients.
Chen L et al.
Nature Communications, 2018
29636477 (PubMed )
Supplement: 41467_2018_3867_MOESM1_ESM.pdf
Mutations of KRAS/NRAS/BRAF predict cetuximab resistance in metastatic colorectal cancer patients.
Hsu HC et al.
Oncotarget, 2016
26989027 (PubMed )
Supplement: oncotarget-07-22257-s001.pdf
Select a paper to view details